Legato Capital Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Legato Capital Management's IRMD Position: Q2 2026 in Review
Legato Capital Management held its iRadimed (IRMD) position steady in Q2 2026 at 6,613 shares worth $632K. The position accounts for 0.05% of the portfolio, ranked #472.
Legato Capital Management first reported a position in IRMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $911K in Q3 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Legato Capital Management held 6,613 shares of iRadimed worth $632K as of Q2 2026.
- Legato Capital Management left its iRadimed share count unchanged in Q2 2026.
- iRadimed made up 0.05% of Legato Capital Management's portfolio in Q2 2026, its #472 holding.
- Legato Capital Management first reported a position in iRadimed in Q2 2023 and has held it in 13 quarters since.
- Legato Capital Management's iRadimed position peaked at $911K in Q3 2025.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.